We are live on ! Find out more
FFVM

Founders Fund V Management Portfolio holdings

AUM $2.16M
1-Year Est. Return 77.37%
This Fund
S&P 500
This Quarter Est. Return
-30.06%
1 Year Est. Return
+77.37%
3 Year Est. Return
+859.57%
5 Year Est. Return
-74.2%
10 Year Est. Return
AUM
$572K
AUM Growth
-$274K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 87.86%
2 Technology 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CYTH
1
DELISTED
Cyclo Therapeutics, Inc. Common Stock
CYTH
$379K 66.35%
480,708
UBX
2
DELISTED
Unity Biotechnology
UBX
$72.3K 12.64%
49,172
RGTI icon
3
Rigetti Computing
RGTI
$4.94B
$69.4K 12.14%
88,621
NTBL
4
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$50.7K 8.87%
117,924

Similar funds

Founders Fund V Management's Q3 2024 Portfolio in Review

As of Q3 2024, Founders Fund V Management held 4 positions worth $572K, down 32% from $846K the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 0%. Founders Fund V Management opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 89% a quarter earlier, followed by Technology.

  • Founders Fund V Management's ten largest holdings make up 100% of its $572K portfolio in Q3 2024.
  • Founders Fund V Management opened 0 new positions and closed 0 in Q3 2024.
  • Founders Fund V Management's portfolio value fell 32% quarter-over-quarter to $572K.

Based on Founders Fund V Management's 13F filing for Q3 2024, filed 14 Nov 2024.